The Deal
Sunday, November 22, 
8:26 am

The week in deals: April 20-24, 2009

  Share     E-Mail    Discussion    Print Story

The moribund M&A market showed some signs of life last week.

The markets digested a flurry of mergers Monday: Oracle Corp. (NASDAQ:ORCL) put in a $7.4 billion bid for struggling Sun Microsystems Corp. (NASDAQ:JAVA); PepsiCo Inc. (NYSE:PEP) made a $6 billion offer to buy out its two largest bottling affiliates, and GlaxoSmithKline plc bid $3.6 billion for Stiefel Laboratories Inc., which would nearly triple the size of its dermatology unit.

The deals may hint at an uptick in the M&A market, but will these mergers benefit the companies involved? The Deal's Olaf de Senerpont Domis pointed out that analysts are still not 100% sold on the merits of Oracle's bid for Sun.

On the pharmaceutical front, where megadeals have been occurring since late last year, Corporate Dealmaker's Kenneth Klee contradicts a recent study that predicts Bristol-Myers Squibb Co. (NYSE:BMY) and Bayer AG could be scooped sometime soon: "It doesn't seem likely we'll be hearing about giant deals from them. Some pharmas think the way to battle shrinking pipelines and the loss of patent protection on blockbuster drugs isn't massive dealmaking."

In the financial sector, it was all about earnings as heavy hitters such as Bank of America Corp. (NYSE:BAC) surpassed expectations. But the data did not lift the shadow on the tenure of CEO Ken Lewis, nor did he help his cause when reports surfaced later in the week that he intentionally withheld information of the acquisition of Merrill Lynch & Co. when he was pressured to follow through with the deal by Federal Reserve Chairman Ben Bernanke and former Treasury Secretary Henry Paulson.

Meanwhile, Morgan Stanley (NYSE:MS) reported a wider-than-expected loss for its first-quarter earnings as the bank was rumored to be interested in acquiring a regional bank. Next week should be another hot one in earnings as Deutsche Bank AG (NYSE:DB) reports on April 28, Boston Properties Inc. (NYSE:BXP) on April 29 and Exxon Mobil Corp. (NYSE: XOM) on April 30.

Just in case, you missed it here's a rundown of last week's top headlines: - Gerald Magpily

M&A
Deal Pipeline: Oracle's conquest continues with Sun (subscription required)
Deal Pipeline: PepsiCo makes $6B bid for bottlers(subscription required)
Deal Pipeline: Glaxo snares Stiefel Labs(subscription required)
Three more pharma megamergers to go? (Corporate Dealmaker)
M&A: Timing is everything (Dealscape)
BofA's shareholders react to Lewis' testimony

EARNINGS
BofA's first quarter tops all of 2008
Morgan Stanley's big earnings miss
BofA's shareholders react to Lewis' testimony
Morgan Stanley's big earnings miss
Citi's new frugality

TECH
Nielsen: Facebook use outstrips e-mail
Oracle wants Java more than IBM did

Continue reading below

Also on Dealscape





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.